ABC transporters in breast cancer: their roles in multidrug resistance and beyond

Anupama Modi1, Dipayan Roy1,2, Shailja Sharma1

  • 1Department of Biochemistry, AIIMS, Jodhpur, India.

Insights

ATP-binding cassette (ABC) transporters are crucial in multidrug resistance and breast cancer (BC) progression. Targeting these transporters offers a promising strategy to improve BC treatment outcomes and patient prognosis.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • ATP-binding cassette (ABC) transporters are membrane proteins critical for cellular transport.
  • These transporters are implicated in multidrug resistance (MDR) in cancer chemotherapy.
  • ABC transporters play significant roles in cancer pathogenesis, prognostics, and therapeutic response.

Purpose of the Study:

  • To provide a comprehensive review of ABC transporters and their specific roles in breast cancer (BC) drug resistance.
  • To highlight key ABC transporters involved in BC chemoresistance and prognosis.
  • To discuss emerging therapeutic strategies targeting ABC transporters in BC.

Main Methods:

  • Literature review of existing clinical and molecular evidence.
  • Analysis of ABC transporter expression in different BC subtypes and metastases.
  • Examination of therapeutic approaches targeting ABC transporters.

Main Results:

  • High expression of ABC transporters, including ABCA1, ABCB1, and ABCG2, is observed in less differentiated BC subtypes and metastases, contributing to chemoresistance.
  • ABCB1 and ABCC1 are identified as significant factors in BC prognosis.
  • Newer therapies aim to inhibit ABC transporters to overcome drug resistance, reduce cell viability, induce apoptosis, and enhance drug sensitivity.

Conclusions:

  • ABC transporters are key drivers of drug resistance and influence prognosis in breast cancer.
  • Inhibiting specific ABC transporters presents a viable strategy to reverse chemoresistance and improve treatment efficacy.
  • Future research focusing on targeted therapies for genetic variations and related molecules holds promise for enhancing patient outcomes in BC.

Related Concept Videos

ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
4.9K
ABC Transporters: Importer01:27

ABC Transporters: Importer

ATP-binding cassette or ABC transporters are a class of ATP-driven pumps that hydrolyze ATP to move solutes across the membrane. They can be grouped into importers and exporters. While exporters are present in all domains of life, importers exist only in bacteria and some plants.
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
2.9K
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
534
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport01:19

Drug Absorption Mechanism: Carrier-Mediated Membrane Transport

Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
4.3K
Active Transport01:14

Active Transport

Active transport is a critical biological process that allows cells to move solutes against an electrochemical gradient. This process requires direct energy input and is characterized by its selectivity, saturability, and susceptibility to competitive inhibition.
Primary active transporters, like Na+, K+ and -ATPase, directly utilize ATP to move ions across the membrane. These transporters play significant roles in various physiological processes. For instance, Na+, K+ and -ATPase maintain...
863